Literature DB >> 27541683

Population-level diversity in the association of genetic polymorphisms of one-carbon metabolism with breast cancer risk.

Shaik Mohammad Naushad1,2, Chandrasekhar Divya3, M Janaki Ramaiah3, Tajamul Hussain4, Salman A Alrokayan5, Vijay Kumar Kutala6.   

Abstract

Aberrations in one-carbon metabolism were reported to increase breast cancer risk by influencing the DNA synthesis and methylation of DNA and catecholamines. However, the results of these association studies remain inconclusive. We have explored the contribution of eight genetic polymorphisms in modulating the susceptibility to breast cancer by performing a meta-analysis of worldwide studies. In total, 62 case-control studies representing 17 different populations involving 18,117 breast cancer cases and 23,573 healthy controls were included in this meta-analysis. Out of the eight polymorphisms analyzed, methylenetetrahydrofolate reductase (MTHFR) C677T exhibited positive association with the breast cancer risk in both fixed effects (OR 1.14, 95 % CI 1.10-1.17) and random effects (OR 1.10, 95 % CI 1.02-1.18) models. Solute carrier family 19 (folate transporter), member 1 (SLC19A1) G80A exhibited positive association (OR 1.16, 95 % CI 1.03-1.31) while MTR A2756G exhibited an inverse association (OR 0.78, 95 % CI 0.75-0.82) with the breast in fixed effect model alone. Significant heterogeneity was observed in the association of MTHFR C677T with breast cancer even between studies from the same geographical area, specifically among Chinese, Indians, and Turks. Subgroup analysis revealed MTHFR C677T-mediated breast cancer risk in post-menopausal women and women with low dietary intake of folate. Geographical area wise segregation of data revealed MTHFR-mediated increased breast cancer risk in populations who consume methionine-rich diet. Altitude-level variations were observed in the association of SHMT1 C1420T with breast cancer. India and Brazil of same altitude showed an inverse association with this polymorphism, while USA and China that share similar altitude showed a null association. MTHFR C677T and SLC19A1 G80A are the two polymorphisms of one-carbon metabolic pathway that increase breast cancer in the worldwide population. Dietary patterns and altitudinal variations are the likely risk modulators that are contributing toward ethnic- and population-level variations in genetic associations.

Entities:  

Keywords:  Altitude; Breast cancer; One-carbon metabolism; Polymorphisms

Year:  2016        PMID: 27541683      PMCID: PMC5138163          DOI: 10.1007/s12687-016-0277-1

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  64 in total

1.  Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers.

Authors:  Vidudala V T S Prasad; Harpreet Wilkhoo
Journal:  Onkologie       Date:  2011-08-22

Review 2.  From candidate gene studies to GWAS and post-GWAS analyses in breast cancer.

Authors:  Laura Fachal; Alison M Dunning
Journal:  Curr Opin Genet Dev       Date:  2015-02-27       Impact factor: 5.578

3.  Single-nucleotide polymorphisms in one-carbon metabolism genes, Mediterranean diet and breast cancer risk: a case-control study in the Greek-Cypriot female population.

Authors:  Maria G Kakkoura; Christiana A Demetriou; Maria A Loizidou; Giorgos Loucaides; Ioanna Neophytou; Yiola Marcou; Andreas Hadjisavvas; Kyriacos Kyriacou
Journal:  Genes Nutr       Date:  2015-01-21       Impact factor: 5.523

4.  Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

Authors:  K F Hoskins; J E Stopfer; K A Calzone; S D Merajver; T R Rebbeck; J E Garber; B L Weber
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

5.  Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer.

Authors:  Naushad Shaik Mohammad; Rupasree Yedluri; Pavani Addepalli; Suryanarayana Raju Gottumukkala; Raghunadha Rao Digumarti; Vijay Kumar Kutala
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

6.  Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan.

Authors:  Chun-Wen Cheng; Jyh-Cherng Yu; Chiun-Sheng Huang; Jia-Ching Shieh; Yi-Ping Fu; Hsiao-Wei Wang; Pei-Ei Wu; Chen-Yang Shen
Journal:  Breast Cancer Res Treat       Date:  2007-09-22       Impact factor: 4.872

7.  One-carbon metabolism-related gene polymorphisms and risk of breast cancer.

Authors:  Takeshi Suzuki; Keitaro Matsuo; Kaoru Hirose; Akio Hiraki; Takakazu Kawase; Miki Watanabe; Toshinari Yamashita; Hiroji Iwata; Kazuo Tajima
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

8.  The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis.

Authors:  Ilan Ifergan; Gerrit Jansen; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

9.  DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR.

Authors:  Meng Hua Tao; Peter G Shields; Jing Nie; Catalin Marian; Christine B Ambrosone; Susan E McCann; Mary Platek; Shiva S Krishnan; Bin Xie; Stephen B Edge; Janet Winston; Dominica Vito; Maurizio Trevisan; Jo L Freudenheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

10.  Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population.

Authors:  Muhammad Akram; F A Malik; Mahmood Akhtar Kayani
Journal:  Asian Pac J Cancer Prev       Date:  2012
View more
  7 in total

1.  Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis.

Authors:  Shao-Jun Ma; Yan-Mei Liu; Yue-Lang Zhang; Ming-Wei Chen; Wei Cao
Journal:  Biosci Rep       Date:  2018-02-02       Impact factor: 3.840

2.  Variants of Genes Involved in Metabolism of Folate Among Patients with Breast Cancer: Association of TYMS 3R Allele with Susceptibility to Breast Cancer and Metastasis.

Authors:  Zohreh Rahimi; Maryam Bozorgi Zarini; Ziba Rahimi; Ebrahim Shakiba; Asad Vaisi-Raygani; Mohammad Taher Moradi; Kheirolah Yari
Journal:  Iran J Pathol       Date:  2020-11-10

3.  Effects of methylenetetrahydrofolate reductase single-nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities.

Authors:  Zheng Wang; Kai Li; Ling Ouyang; Hidasa Iko; Ahmad Javid Safi; Shan Gao
Journal:  Chronic Dis Transl Med       Date:  2021-08-12

4.  A comprehensive meta-analysis and a case-control study give insights into genetic susceptibility of lung cancer and subgroups.

Authors:  Debmalya Sengupta; Souradeep Banerjee; Pramiti Mukhopadhyay; Ritabrata Mitra; Tamohan Chaudhuri; Abhijit Sarkar; Gautam Bhattacharjee; Somsubhra Nath; Susanta Roychoudhury; Samsiddhi Bhattacharjee; Mainak Sengupta
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

5.  Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.

Authors:  Hanaa Hardi; Rahma Melki; Zouhour Boughaleb; Tijani El Harroudi; Souria Aissaoui; Noureddine Boukhatem
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

Review 6.  Association of folate intake and plasma folate level with the risk of breast cancer: a dose-response meta-analysis of observational studies.

Authors:  Xueting Ren; Peng Xu; Dai Zhang; Kang Liu; Dingli Song; Yi Zheng; Si Yang; Na Li; Qian Hao; Ying Wu; Zhen Zhai; Huafeng Kang; Zhijun Dai
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

7.  MassARRAY-based single nucleotide polymorphism analysis in breast cancer of north Indian population.

Authors:  Divya Bakshi; Ashna Nagpal; Varun Sharma; Indu Sharma; Ruchi Shah; Bhanu Sharma; Amrita Bhat; Sonali Verma; Gh Rasool Bhat; Deepak Abrol; Rahul Sharma; Samantha Vaishnavi; Rakesh Kumar
Journal:  BMC Cancer       Date:  2020-09-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.